FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2291846189> ?p ?o ?g. }

• W2291846189 endingPage "16" @default.
• W2291846189 startingPage "15" @default.
• W2291846189 abstract "Gastrointestinal NursingVol. 14, No. 1 Skills in PracticeRifaximin: its role, indication and efficacy in treating hepatic encephalopathyAdam RiedlingerAdam RiedlingerSearch for more papers by this authorAdam RiedlingerPublished Online:28 Feb 2016https://doi.org/10.12968/gasn.2016.14.1.15AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References Bajaj JS (2016) Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis. Aliment Pharmacol Ther 43(Suppl 1): 11–26. doi: https://doi.org/10.1111/apt.13435 Crossref, Google ScholarBajaj JS, Wade JB, Sanyal AJ (2009) Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology 50(6): 2014–21. doi: https://doi.org/10.1002/hep.23216 Crossref, Google ScholarBass NM, Mullen KD, Sanyal A et al. (2010) Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362(12): 1071–81. doi: https://doi.org/10.1056/NEJMoa0907893 Crossref, Google ScholarBernal W, Wendon J (2013) Acute liver failure. N Engl J Med 369(26): 2525–34. doi: https://doi.org/10.1056/NEJMra1208937 Crossref, Google ScholarDuPont HL (2015) Rifaximin: an antibiotic with important biologic effects. Mini Rev Med Chem 16(3): 200–5 Crossref, Google ScholarFerenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy—definition, nomenclature, diagnosis, and qualification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35(3): 716–21 Crossref, Google ScholarFrederick RT (2011) Current concepts in the pathophysiology and management of hepatic encephalopathy. Gastroenterol Hepatol 7(4): 222–33 Google ScholarHassanein T, Blei AT, Perry W et al. (2009) Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy. Am J Gastroenterol 104(6): 1392–400. doi: https://doi.org/10.1038/ajg.2009.160 Crossref, Google ScholarKimer N, Krag A, Bendtsen F, Møller S, Gluud LL (2015) Rifaximin for people with hepatic encephalopathy. bit.ly/1ZEnua3 (accessed 21 January 2016) Google ScholarKoo HL, DuPont HL (2010) Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol 26(1): 17–25. doi: https://doi.org/10.1097/MOG.0b013e328333dc8d Crossref, Google ScholarLeise MD, Poterucha JJ, Kamath PS, Kim WR (2014) Management of hepatic encephalopathy in the hospital. Mayo Clinic Proc 89(2): 241–53. doi: https://doi.org/10.1016/j.mayocp.2013.11.009 Crossref, Google ScholarMohammad RA, Regal RE, Alaniz C (2012) Combination therapy for the treatment and prevention of hepatic encephalopathy. Ann Pharmacother 46(11): 1559–63. doi: https://doi.org/10.1345/aph.1R146 Crossref, Google ScholarPatidar KR, Bajaj JS (2013) Antibiotics for the treatment of hepatic encephalopathy. Metab Brain Dis 28(2): 307–12. doi: https://doi.org/10.1007/s11011-013-9383-5 Crossref, Google ScholarPatidar KR, Thacker LR, Wade JB et al. (2014) Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol 109(11): 1757–63. doi: https://doi.org/10.1038/ajg.2014.264 Crossref, Google ScholarRiordan SM, Williams R (2010) Gut flora and hepatic encephalopathy in patients with cirrhosis. N Engl J Med 362(12): 1140–2. doi: https://doi.org/10.1056/NEJMe1000850 Crossref, Google ScholarScarpignato C, Pelosini I (2005) Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential. Chemotherapy 51(Suppl 1): 36–66 Crossref, Google ScholarSharma BC, Sharma P, Lunia MK, Srivastava S, Goyal R, Sarin SK (2013) A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol 108(9): 1458–63. doi: https://doi.org/10.1038/ajg.2013.219 Crossref, Google ScholarStewart CA, Malinchoc M, Kim W, Kamath PS (2007) Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 13(10): 1366–71 Crossref, Google ScholarTeasdale G, Jennett B (1974) Assessment of coma and impaired consciousness: a practical scale. Lancet 2(7872): 81–4. Crossref, Google ScholarVilstrup H, Amodio P, Bajaj J et al. (2014) Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60(2): 715–35. doi: https://doi.org/10.1002/hep.27210 Crossref, Google ScholarZeneroli ML, Avallone R, Corsi L, Venturini I, Baraldi C, Baraldi M (2005) Management of hepatic encephalopathy: role of rifaximin. Chemotherapy 51(Suppl 1): 90–5 Crossref, Google ScholarZhu GQ, Shi KQ, Huang S et al. (2015) Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy. Aliment Pharmacol Ther 41(7): 624–35. doi: https://doi.org/10.1111/apt.13122 Crossref, Google Scholar FiguresReferencesRelatedDetails 2 February 2016Volume 14Issue 1ISSN (print): 1479-5248ISSN (online): 2052-2835 Metrics History Published online 28 February 2016 Published in print 2 February 2016 Information© MA Healthcare LimitedPDF download" @default.
• W2291846189 created "2016-06-24" @default.
• W2291846189 creator A5064023312 @default.
• W2291846189 date "2016-02-02" @default.
• W2291846189 modified "2023-09-26" @default.
• W2291846189 title "Rifaximin: its role, indication and efficacy in treating hepatic encephalopathy" @default.
• W2291846189 cites W1603121691 @default.
• W2291846189 cites W1973051170 @default.
• W2291846189 cites W1982049192 @default.
• W2291846189 cites W1993971924 @default.
• W2291846189 cites W2005061129 @default.
• W2291846189 cites W2026317976 @default.
• W2291846189 cites W2029773497 @default.
• W2291846189 cites W2053629542 @default.
• W2291846189 cites W2083754290 @default.
• W2291846189 cites W2091958019 @default.
• W2291846189 cites W2099360240 @default.
• W2291846189 cites W2105932465 @default.
• W2291846189 cites W2113992770 @default.
• W2291846189 cites W2121076704 @default.
• W2291846189 cites W2132317826 @default.
• W2291846189 cites W2132421564 @default.
• W2291846189 cites W2146276801 @default.
• W2291846189 cites W2186320679 @default.
• W2291846189 cites W2407938587 @default.
• W2291846189 cites W4242966060 @default.
• W2291846189 doi "https://doi.org/10.12968/gasn.2016.14.1.15" @default.
• W2291846189 hasPublicationYear "2016" @default.
• W2291846189 type Work @default.
• W2291846189 sameAs 2291846189 @default.
• W2291846189 citedByCount "0" @default.
• W2291846189 crossrefType "journal-article" @default.
• W2291846189 hasAuthorship W2291846189A5064023312 @default.
• W2291846189 hasConcept C126322002 @default.
• W2291846189 hasConcept C2777214474 @default.
• W2291846189 hasConcept C2778621155 @default.
• W2291846189 hasConcept C2778889925 @default.
• W2291846189 hasConcept C2780325230 @default.
• W2291846189 hasConcept C41260117 @default.
• W2291846189 hasConcept C501593827 @default.
• W2291846189 hasConcept C71924100 @default.
• W2291846189 hasConcept C86803240 @default.
• W2291846189 hasConcept C89423630 @default.
• W2291846189 hasConcept C90924648 @default.
• W2291846189 hasConceptScore W2291846189C126322002 @default.
• W2291846189 hasConceptScore W2291846189C2777214474 @default.
• W2291846189 hasConceptScore W2291846189C2778621155 @default.
• W2291846189 hasConceptScore W2291846189C2778889925 @default.
• W2291846189 hasConceptScore W2291846189C2780325230 @default.
• W2291846189 hasConceptScore W2291846189C41260117 @default.
• W2291846189 hasConceptScore W2291846189C501593827 @default.
• W2291846189 hasConceptScore W2291846189C71924100 @default.
• W2291846189 hasConceptScore W2291846189C86803240 @default.
• W2291846189 hasConceptScore W2291846189C89423630 @default.
• W2291846189 hasConceptScore W2291846189C90924648 @default.
• W2291846189 hasIssue "1" @default.
• W2291846189 hasLocation W22918461891 @default.
• W2291846189 hasOpenAccess W2291846189 @default.
• W2291846189 hasPrimaryLocation W22918461891 @default.
• W2291846189 hasRelatedWork W1799090311 @default.
• W2291846189 hasRelatedWork W2068067473 @default.
• W2291846189 hasRelatedWork W2233063448 @default.
• W2291846189 hasRelatedWork W2382369664 @default.
• W2291846189 hasRelatedWork W2895862229 @default.
• W2291846189 hasRelatedWork W2969547143 @default.
• W2291846189 hasRelatedWork W2971309707 @default.
• W2291846189 hasRelatedWork W3030351087 @default.
• W2291846189 hasRelatedWork W3158300244 @default.
• W2291846189 hasRelatedWork W3203853037 @default.
• W2291846189 hasVolume "14" @default.
• W2291846189 isParatext "false" @default.
• W2291846189 isRetracted "false" @default.
• W2291846189 magId "2291846189" @default.
• W2291846189 workType "article" @default.